Aiming to map the distribution of spinally projecting, hypothalamic neurons containing neuronal nitric oxide synthase (nNOS), True Blue (TB) is injected into the rat spinal cord. After survival times of 7 to 14 days the animals are anaesthetized and perfused transcardially with a solution containing paraformaldehyde and sucrose. After dissection, the injection site is further fixed for 4-8 hours, cut in a cryostat and documented by computer assisted digital photography. The brain region of interest is fixed for four hours, rinsed in phosphate buffer for 48 hours, sectioned and photographically documented utilizing filter settings for visualization of TB. The brain sections are then immunohistochemically processed using a primary antibody against nNOS and a Texas Red (TR)-labelled secondary antibody and once again photographically documented, now using filter settings for visualization of TB and TR respectively. Utilizing the Photoshop program, the TB containing cells can then be exactly aligned and the presence of TB and/or TR fluorescence in the same cell bodies are evaluated. This method for neurotransmitter-specific retrograde tracing derives its high sensitivity from the optimization of fixation/rinsing parameters, the use of appropriate fluorophores and sequential digital microphotography.
Introduction
The combination of retrograde tracing and immunohistochemistry allows for mapping of axonal projections of cell bodies containing a defined neurotransmitter or transmitterrelated enzyme. Such methods were described already in the mid seventies utilizing conventional light-microscopy and photography. The technique initially relied on the different distribution and morphology of Horse Radish Peroxidase, whether bound to an antibody for visualising the transmitter, or retrogradely transported from a distal injection site in order to demonstrate the neuronal projection [7] . A simpler and apparently more sensitive technique was later provided by the combination of a natively fluorescent retrograde tracer [6] with either fluorescence histochemistry [3] or immunofluorescence [10] utilizing fluorophores with non-overlapping spectral characteristics [5] . A protocol for the latter method was provided by Sawchenko and Swanson [10] , who used the fluorescent retrograde tracer True Blue (TB) in combination with immunofluorescence utilizing a fluorescein isothiocyanate (FITC)-labelled secondary antibody. Although these methods were shown to be highly useful, they are somewhat cumbersome to use, mainly because conventional photography is time consuming and sometimes difficult to perform because of insufficient fluorescence intensity of the tracer. Furthermore, the sensitivity of the technique sometimes appears less than optimal probably due to partly overlapping spectral characteristics, diffusion and fading of the retrograde tracer during tissue processing and the consequent need for long photographic exposure times when using conventional photography. These drawbacks are largely overcome by the present protocol, which utilizes a modified procedure for tissue processing in combination with fluorophores with non-overlapping spectral characteristics, and takes advantage of the recent developments for digitalized photography which allows for short exposure times and subsequent, but immediate, computerized image analysis and processing. Utilizing TB in combination with a neuronal nitric oxide synthase (nNOS) antibody, the nitrergic projections originating in the hypothalamic paraventricular nucleus (PVN) was investigated [9] . In this protocol retrogradely transported TB and Texas Red (TR) bound to the secondary antibody are selectively visualized using amino methylcoumarin acetic acid (AMCA) and TR filter settings respectively.
Type of research
Neuroanatomical studies concerned with the origins, projections and terminations of neuronal systems containing a specified neurotransmitter.
Time required
Seven to 14 days for retrograde tracing. Approximately 8 h for preparation of sections and photography session I. Approximately 24 h for immunohistochemical processing and photography session II. Thus, the complete protocol can be executed in approximately 9 to 16 days.
Materials

Animals
Female virgin Sprague-Dawley rats weighing 200-300 g (B&K Universal, Sollentuna, Sweden) are housed, up to four animals together in each cage, under standard laboratory conditions. The rats have free access to water and standard pellets and are housed under controlled conditions at 22 ± 2°C with 12 h of light and 12 h of darkness (the experimental protocol was approved by the Animal Ethics Committee, University of Lund). 
Special equipment
Retrograde tracer
-TB (EMS-POLYLOI GmbH, Groß-Umstadt, Germany) A 3% weight/volume (w/v) suspension of TB is prepared by suspending 3 µg of TB in 0.1 ml distilled water and sonicating for 10 minutes (sonicator; Model B-30, Branson Sonic Power Company, Danbury, CT, USA). This suspension may be stored in a refrigerator for at least 6 months without appreciable loss of fluorescence intensity. 
Antibodies
Solutions
-Ca 2+ -free Krebs (CafKr): 1000 ml is prepared as follows: 6.954 g NaCl, 1.26 g NaHCO 3 , 0.343 g KCl, 0.244 mg MgCl 2 x6H 2 O and 0.1656 g NaH 2 PO 4 xH 2 0 is dissolved in 950 ml distilled H 2 O. Make 1000 ml of 0.01M EGTA by adding 5 ml of 1M NaOH to 900 ml distilled H 2 O. Add 3.80 g of EGTA and adjust pH to 7.4 with glacial acetic acid and dilute with distilled H 2 O to 1000 ml containing heparin (10000 IE/l) and sodium nitrite (2 g/l). Add 10 ml of this stock solution to the above solution and dilute with distilled H 2 O to 1000 ml. -1000 ml PBS containing 4% formaldehyde and 15% sucrose (FAsPBS) is prepared as follows: Dissolve 40 g paraformaldehyde in 64 ml distilled H 2 O at 70° C during continous stirring. Add 30 drops of 1 M NaOH with a pasteur pipette. Keep stirring until the solution is clear. Add 900 ml PBS (recipe as below). Adjust pH to 7.4 with 1 M NaOH. Dissolve 150 g of sucrose in the solution to reach a final volume of 1000 ml. -PBS buffer (PBS): Make 1000 ml solutions with distilled H 2 O of the following: KH 2 PO 4 9.073 g/l (solution A), Na 2 HPO 4 x2H 2 O 11.866 g/l (solution B), NaCl 45 g/l (solution C). To make 1000 ml PBS take 60 ml of solution A, 140 ml of solution B and 800 ml of solution C. Adjust pH to 7.2 with 1M NaOH or 1M HCl. -100 ml PBS/glycerol containing 1,4-phenylene diamine (PBSgp) is prepared as follows (during cold and dark conditions): 100 mg 1,4-phenylenediamine (not in lumps) is diluted in 10 ml PBS (+4° C) during stirring and use of a glass rod. Add 90 ml glycerol (+4° C). Store in darkness at -20° C. -1000 ml PBS containing 15% sucrose (sPBS) is prepared as follows: Dissolve 150 g sucrose in PBS to reach a volume of 1000 ml. -1000 ml 0.2% Triton in PBS (TrPBS) is prepared as follows: Dissolve 2 ml Triton X-100 in PBS and dilute to 1000 ml. Purchased antibodies were prepared as follows: Freeze dried primary antibody (50 µl) was diluted with 50 µl distilled H 2 O and then diluted with 950 µl PBS to get a concentration of 1:20 and then divided into aliquots and frozen at -20° C. Freeze dried secondary antibody (0.3 mg) was first diluted with 250 µl distilled H 2 O and thereafter with 250 µl of glycerol, to get a concentration of 1:2 and then divided into aliquots and frozen at -20° C.
Detailed procedure
Tracer injection 5.1.1 Anaesthesia and surgical exposure
During the light period, the animals are anaesthetized with a mixture of ketamine (50 mg/kg) and xylazine (10 mg/kg), administered intramuscularly.
Surgery
The animals are secured in a stereotaxic frame with the tooth bar fixed as high as possible. For injection into the spinal cord, a moderate weight is attached to the tail of the animal in order to lift the body so that the thorax can freely expand downwards with inspiration, thereby minimizing movement of the back, so that the spinal cord is almost totally immobilized. The spinal cord is exposed through a midline skin incision followed by stripping the longitudinal muscles, from one or two vertebrae and making a small laminectomy.
Tracer injection
Under surveillance through the operating microscope the dura is incised longitudinally, whereafter 0.2-0.8 µl of the TB suspension (see Section 4.3) is injected into the spinal cord via a 10 µl Hamilton Syringe during 1-2 minutes. The syringe is left in place for 5 minutes before being slowly withdrawn. Any sign of leakage of tracer observed through the microscope are washed with 0.9% saline and removed with a piece of surgical sponge. The vertebral muscles are approximated by 4.0 sutures and the skin incision sealed by stapling. The animals are then permitted to wake up before they are again caged (and allowed to survive for 7-14 days).
Preparation of tissue
After 7-14 days, the animals are anaesthetized as in Section 5.1.1. The rats are then perfused transcardially through the ascending aorta, first with 100 ml of CafKr at +4° C, followed by fixation with 250 ml of FAsPBS at +4° C (see Section 4.5). The parts of the spinal cord which contain the TB injection-site are dissected and immersion-fixed in FAsPBS for 4 to 8 h and directly frozen in isopentane (-40° C) until the end of "boiling" and then stored at -70° C. When convenient, serial cryostat sections are cut at -20° C, perpendicularly to the longitudinal axis of the spinal cord at a thickness of 10 µm. Following perfusion fixation, the brains are dissected out. Small identifying cuts are made in the cortex ipsilaterally to the injection site in frontal slices, which are about 7 mm thick, containing the region of interest. The slices are immersion-fixed in FAsPBS at +4° C for 4 h and rinsed in sPBS at +4° C for 48 h (three rinses), frozen and stored as above. Serial cryostat sections are cut in the frontal plane at a thickness of 10 µm at -20°C. Relevant sections are thaw-mounted onto chrome alum coated slides, and processed as below (Section 5.3-5.5).
Photography session I
Using a microscope connected to a digital camera and equipped with appropriate filter settings (Section 4.2), each injection site is examined and photographed using AMCA and FITC filters (Fig. 1) . The FITC filter setting is used for delineating the most intense zone of the injection site (zone I; Fig. 1 ) [11] . Only animals without signs of leakage and meningeal accumulation of TB are used. TB fluorescence is examined and photographed in the relevant brain areas (Fig. 2A) .
Immunohistochemical processing
All incubations below, are performed in moisture chambers at room temperature if not otherwise stated. After photography session I, the sections to be examined for retrograde labelling are first immersed in TrPBS for 2 h, and subsequently with rabbit nNOS antiserum (1:980; [1,2,8,9]) at +4° C overnight. The following day the sections are rinsed in PBS (3x3 min) and further incubated with TR-conjugated donkey anti-rabbit affinity purified F(ab) 2 fragments, dissolved in TrPBS, for 90 min. Finally, the sections are rinsed in PBS (3x3 min) and mounted in PBSgp (Section 4.5). The sections are either handled directly according to Section 5.5 (see below) or stored at -20° C and subsequently handled according to Section 5.5 when convenient (see below).
Photography session II
After the immunohistochemical processing, the brain structures documented in photography session I are again photographed. Both nNOS-TR immunofluorescence and the TB fluorescence which remains after the immunohistochemical processing are documented in the computer using appropriate filter settings. The pattern of the remaining TB fluorescence may be used as template to facilitate alignment, with the corresponding image from photography session I, obtained before immunohistochemical processing.
Image processing and evaluation
In the majority of cases stored images from photography session I and II are processed using a two layer technique in Adobe Photoshop (in rare cases three layers are used). The image of TB fluorescence obtained in photography session I is used as layer one. The colour image of immunoreactivity (TR fluorescence) is converted to greyscale and thereafter inverted, thus showing immunoreactive neurons black on a white background. This image is used as layer two on top of the TB image obtained in photography session I. By using the opacity regulator in the Photoshop program, it is possible to make layer two more or less transparent (Fig. 3) . In almost every case there is a miss-match in alignment, between layer one and layer two, due to the difficulties of photographing exactly the same field of view in photography session I and II. When the direction of the miss-match has been visually established, layer two is temporarily removed, and layer one is rotated in order to minimize the miss-match (Fig. 3) . Finally, layer two is reintroduced, and horisontally and vertically matched with layer one. By repeating this procedure, a perfect match of layer one and layer two is obtained. From this match a double image can be constructed simultaneously visualising TB fluorescence and immunoreactivity in exactly the same field of view (Fig. 3) . Thus, in every structure documented in this way, co-localization and non co-localization of TB fluorescence and immunoreactivity can, within the same neuronal structures, be definitely established.
Results
As shown in figure 2 the appropriate filter setting reveals either the fluorescent tracer as a light blue, mainly cytoplasmatic light blue fluorescence against a dark back-ground or, alternatively, the distribution of the TR-labelled secondary antibody in cell bodies and fibres as a bright-red fluorescence against a dark-red background. Trying to optimize the possibility to distinguish between TR and TB, the image of immunoreactivity (layer 2) was first converted to greyscale and then inverted in Photoshop ® creating a picture exhibiting dark neurons on a light background (see Fig. 3) . By comparing the appearance of labelling within the two layers at different degrees of transparency (by using the opacity regulator; Fig. 3 ) the absence or presence of either type of fluorescence ("retrograde" or "immunoreactive") can readily be assessed within any chosen area of interest. Neuronal cell bodies were observed that contained both TB fluorescence and nNOSimmunoreactivity, together with cell bodies that contained either TB fluorescence or nNOS-immunoreactivity (see Fig. 2 ). A marked reduction of TB fluorescence was found when comparing the sections containing TB at the region of interest before and after immunohistochemical processing (Fig. 4) .
Discussion
In comparison with previous methods the present protocol derives its superior sensitivity and convenience from three main factors, which together with some comments relating to the delineation of the injection site will be discussed in paragraphs below.
Injection site
Although the relation between the appearance of the injection site and the area of efficient uptake of tracer is difficult to determine, it seems very important to try to visualise the injection site and if possible to describe it in at least semi-quantitative terms. In this protocol we have chosen to visualise the injection site using two different filter settings providing both optimal and clearly suboptimal excitation of TB fluorescence (using the AMCA and FITC filter settings, respectively) in order to quantitatively delineate three different zones of the injection site (Fig. 1) [11] . By keeping the tissue that contains the injection site, in sucrose-containing fixative until freezing and sectioning, we have aimed at minimizing postmortem diffusion of the tracer.
Tissue handling
By adding sucrose to the fixative and keeping the tissue in this fixative until sectioning post-mortem reduction of the tracer intensity is minimized until its distribution has been documented in photography-session I. Although some tracer fluorescence remains after the immunohistochemical processing there appears to be a marked wash-out of TB during this step, usually leaving enough TB to allow for orientation, though clearly not sufficient for anatomical mapping purposes (Fig. 4) . While we did not found the present procedure including mounting and cover-slipping to cause troublesome shrinkage or elastic changes, the protocol may well be applied as an on-slide method if such morphological artefacts represents a concern.
Spectral characteristics
As shown in figure 5 both the excitation and emission spectra for TB and TR differ widely with virtually no overlap allowing for selective visualization of either fluorochrome [3, 4] . This provides a clear-cut advantage in comparison with FITC whose spectral characteristics lie in between a partly overlap with both TB and TR. In this study an AMCA filter is used to detect TB.
Computerized photography and image handling
The use of light sensitive digital cameras has two major advantages: First, they drastically reduce the required exposure time and accordingly the fading of fluorescence. Second, digital cameras allow a direct and repeated documentation, if required. In rare cases the TB image from photography session II may be used as a third layer to facilitate orientation.
Quick procedure
Tracer injection 10-14 days survival Perfusion and subsequent immersionfixation. Cryostat sectioning Photographic session I Immunohistochemical processing Photographic session II
Acknowledgements
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